Award-winning Blinkcns Inc. and MUSC ink new deal for central nervous system disorders technology
The Zucker Institute for Innovation Commercialization (ZI), a technology accelerator and component of the Office of Innovation at the Medical University of South Carolina (MUSC), and Blinkcns Inc. have entered into a strategic, exclusive licensing agreement to advance the novel blink reflex technology and software known as EyeStat.
07.27.22 by blinkcns/MUSC
WaveGuide Corporation CEO, Nelson Stacks, Appointed to Board of Directors of Blinkcns, Inc.
Nelson Stacks brings to blinkcns a wide range of skills, industry exposure, and leadership. He is a serial entrepreneur with nearly 30 years of broad turn-around experience in Biopharma, Diagnostics and Medical Devices.
10.13.21 by blinkcns
Five New ‘Key Opinion Leaders’ Appointed to Blinkcns Scientific Advisory Board
Dr. Angelo Antonini, Dr. Matteo Bologna, Roy Jones, Dr. Fidias Leon-Sarmiento, and Dr. Fabrizio Stocchi, will help guide company as they advance central nervous system research
3.30.21 by blinkcns
EyeStat Wins 2020 InnoVision Technology Development Award
11.17.20 by InnoVision South Carolina
InnoVision awards recognizes innovation in South Carolina annually through its InnoVision Awards program. This year, InnoVision received a record number of applications reflecting both the strength of the innovation economy in South Carolina and the special circumstances of the 2020 pandemic.
Former Lundbeck CNS
Executive, Patrick Cashman, Appointed VP, Neurosciences of Blinktbi, Inc
Blinktbi, Inc., a medical device company exploring non-invasive blink reflex technology for a variety of neurological states and conditions, today announced the appointment of Patrick Cashman as Vice President, Neurosciences, effective immediately.
9.16.20 by blinkcns
8.27.2020 by blinkcns
